BIIB
Price
$137.56
Change
+$1.89 (+1.39%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
19.89B
26 days until earnings call
OGN
Price
$10.13
Change
+$0.02 (+0.20%)
Updated
Sep 26, 04:43 PM (EDT)
Capitalization
2.63B
34 days until earnings call
Interact to see
Advertisement

BIIB vs OGN

Header iconBIIB vs OGN Comparison
Open Charts BIIB vs OGNBanner chart's image
Biogen
Price$137.56
Change+$1.89 (+1.39%)
Volume$34.27K
Capitalization19.89B
Organon & Co
Price$10.13
Change+$0.02 (+0.20%)
Volume$7.94K
Capitalization2.63B
BIIB vs OGN Comparison Chart in %
Loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIIB vs. OGN commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Buy and OGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (BIIB: $135.67 vs. OGN: $10.12)
Brand notoriety: BIIB: Notable vs. OGN: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BIIB: 81% vs. OGN: 72%
Market capitalization -- BIIB: $19.89B vs. OGN: $2.63B
BIIB [@Pharmaceuticals: Major] is valued at $19.89B. OGN’s [@Pharmaceuticals: Major] market capitalization is $2.63B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $640.6B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 0 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • BIIB’s FA Score: 0 green, 5 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, OGN is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 5 TA indicator(s) are bullish while OGN’s TA Score has 5 bullish TA indicator(s).

  • BIIB’s TA Score: 5 bullish, 4 bearish.
  • OGN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BIIB is a better buy in the short-term than OGN.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а -5.66% price change this week, while OGN (@Pharmaceuticals: Major) price change was -6.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.02%. For the same industry, the average monthly price growth was -0.27%, and the average quarterly price growth was +12.71%.

Reported Earning Dates

BIIB is expected to report earnings on Oct 22, 2025.

OGN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.02% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIIB($19.9B) has a higher market cap than OGN($2.63B). BIIB has higher P/E ratio than OGN: BIIB (12.98) vs OGN (3.76). BIIB YTD gains are higher at: -11.280 vs. OGN (-30.616). BIIB has higher annual earnings (EBITDA): 2.79B vs. OGN (1.5B). BIIB has more cash in the bank: 2.76B vs. OGN (599M). BIIB has less debt than OGN: BIIB (6.6B) vs OGN (8.9B). BIIB has higher revenues than OGN: BIIB (10B) vs OGN (6.28B).
BIIBOGNBIIB / OGN
Capitalization19.9B2.63B756%
EBITDA2.79B1.5B187%
Gain YTD-11.280-30.61637%
P/E Ratio12.983.76345%
Revenue10B6.28B159%
Total Cash2.76B599M461%
Total Debt6.6B8.9B74%
FUNDAMENTALS RATINGS
BIIB: Fundamental Ratings
BIIB
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
74
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIIBOGN
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
58%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 10 days ago
55%
Bullish Trend 9 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AULNX115.85N/A
N/A
American Century Ultra® G
DLDRX46.61-0.09
-0.19%
BNY Mellon Natural Resources I
JORNX20.90-0.11
-0.52%
Janus Henderson Global Select T
IVVIX19.98-0.14
-0.70%
Macquarie Smid Cap Core Fund Class I
RSINX16.41-0.17
-1.03%
Victory RS Investors A

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with PFE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
-1.45%
PFE - BIIB
55%
Loosely correlated
-2.03%
MRK - BIIB
51%
Loosely correlated
-2.60%
AMGN - BIIB
49%
Loosely correlated
-2.88%
GSK - BIIB
46%
Loosely correlated
-1.64%
NVS - BIIB
46%
Loosely correlated
-0.63%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with BIIB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
-2.79%
BIIB - OGN
40%
Loosely correlated
-1.45%
GSK - OGN
39%
Loosely correlated
-1.64%
PFE - OGN
38%
Loosely correlated
-2.03%
AZN - OGN
36%
Loosely correlated
-2.43%
SNY - OGN
35%
Loosely correlated
-2.87%
More